Kidney function affects new antibiotic breakdown
NCT ID NCT06672276
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the body processes an experimental antibiotic called TQD3606 in people with different levels of kidney function. 32 adults received a single dose, and researchers measured drug levels in blood and urine. The goal was to understand safety and drug clearance, not to treat any infection. Results will help guide future dosing for patients with kidney issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)
Jinan, Shandong, 250014, China
-
The Second Hospital of Shandong University
Jinan, Shandong, 250014, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?
- Could a phone app be the key to managing kidney disease?
- A new pill aims to slow kidney failure and save lives
- AI takes on kidney disease: a new model to forecast Who's at risk